$70.02—Stale · unknown old
XETRA • Last print unknown ago
$70.02—Stale · unknown old
Corteva Inc is a leading provider of agricultural inputs, specializing in seeds and crop protection products. With a strong presence in North America and Latin America, it leverages advanced biotechnology and digital agriculture to enhance crop yields and sustainability.
Corteva generates revenue through the sale of genetically engineered seeds and crop protection chemicals. Its competitive advantages include a robust R&D pipeline, proprietary traits in seeds, and a strong distribution network that allows for effective market penetration.
Global agricultural commodity prices, particularly corn and soybeans, which impact farmer purchasing decisions
Regulatory approvals for new genetically modified seeds
Weather patterns affecting crop yields
Market share changes against competitors like Bayer and Syngenta
Regulatory changes impacting genetically modified organisms (GMOs)
Climate change affecting agricultural productivity
Intensifying competition from major players like Bayer and BASF
Emerging biotech firms with innovative crop solutions
Low return on equity (4.7%) may limit growth potential
Potential for increased capital expenditures in R&D
moderate - Agricultural inputs are somewhat insulated from economic downturns, but demand can fluctuate with commodity prices and farmer income.
Low - While higher interest rates can increase financing costs for farmers, the impact on Corteva's valuation is limited due to its low debt levels.
minimal - Corteva's operations are not heavily reliant on credit markets, given its low debt-to-equity ratio.
growth - Investors are likely attracted by Corteva's innovation in agricultural technology and potential for revenue expansion.
moderate - The stock has shown a historical beta around 1.2, indicating some sensitivity to market movements.